BioStorage Technologies Appoints New Director of Business Development for European Operations
BioStorage Technologies has announced the appointment of Piet Smet as Director of Business Development for its Europe operations. Smet joins BioStorage Technologies with more than 20 years of experience in sales and operational management within the clinical research area. In his new role, Smet will be responsible for leading the Europe sales team and overseeing the development of new and existing customer relationships.
Prior to joining BioStorage Technologies, Smet founded and managed PS consulting, a firm providing long-term and project-based management support for service companies in the life sciences industry. Smet has also held high-level management positions with BARC Central Laboratory and MSOURCE, an international contract research organization. Piet holds a Bachelor of Psychiatric Nursing degree.
Organizations
Other news from the department people

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
More news from our other portals
Last viewed contents
Dharmacon and amaxa collaborate to improve siRNA delivery into cells
Caprotec bioanalytics Adds Two Patents to its Patent Estate
Study reveals need for personalized approach in treatment of AML
Tai_chi_chuan
Shiquan_dabu_pills
Archemix and SomaLogic Align to Advance the Use of Aptamers - Alliance Promotes Development of Novel Diagnostics and Therapeutics
Protein ID Mapping Service Available Free at Ariadne Genomics Web Site
ImmunoGen, Inc. Expands Pipeline of Targeted Anticancer Compounds - Company to Develop TAP Compound to Novel Target Using Centocor Antibody
